Kynam Capital Management, LP

13F Holdings History for Celldex Therapeutics, Inc. - Common Stock, par value $.001 (CLDX)

Symbol: CLDX on Nasdaq
Investment type: Equity / Common Stock, par value $.001
Latest Disclosed Ownership: 6.5M shares
Security Ownership: 9.79%

Shares, Excluding Options vs Price

Value, Excluding Options

Kynam Capital Management, LP ownership in Celldex Therapeutics, Inc. Common Stock, par value $.001 (CLDX)

2025-05-15 - Kynam Capital Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.5M shares of Celldex Therapeutics, Inc. Common Stock, par value $.001 (CLDX). This represents 9.79% percent ownership of the company. In their previous filing dated 2025-02-14, Kynam Capital Management, LP had reported owning 5.06M shares, indicating an increase of 28.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Kynam Capital Management, LP	9.79%	+27%	$104M	6.5M	+1,435,793	+28.4%	$15.94	13G/A	3/31/2025	15 May 2025 11:48:13
Kynam Capital Management, LP	7.63%		$80.7M	5.06M			$15.94	13G/A	12/31/2024	14 Feb 2025 17:16:09

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		11.8%		$158M	6.1M			$25.87	Q3 2025
6/30/2025		13.4%	-0.87%	$124M	6.1M	-399,271	-6.14%	$20.35	Q2 2025
3/31/2025		10.1%	+2.23%	$118M	6.5M	+1,435,793		$18.15	Q1 2025
12/31/2024		8.44%	+2.68%	$128M	5.06M	+1,605,598	+46.4%	$25.27	Q4 2024
9/30/2024		9.11%	+0.18%	$118M	3.46M	+69,642	+2.05%	$33.99	Q3 2024
6/30/2024		13.1%	+2.01%	$125M	3.39M	+488,967	+16.9%	$37.01	Q2 2024
3/31/2024		13.5%	-0.5%	$122M	2.9M	-105,904	-3.52%	$41.97	Q1 2024
12/31/2023		13.5%	-1.26%	$119M	3.01M	-194,096	-6.07%	$39.66	Q4 2023
9/30/2023		14.4%	+2.7%	$88.1M	3.2M	+600,000	+23.1%	$27.52	Q3 2023
6/30/2023		12.1%	+5.56%	$88.2M	2.6M	+1,190,549	+84.5%	$33.93	Q2 2023
3/31/2023		6.55%	-0.91%	$50.7M	1.41M	-195,939	-12.2%	$35.98	Q1 2023
12/31/2022		11%	+0.04%	$71.6M	1.61M	+5,263	+0.33%	$44.57	Q4 2022
9/30/2022		9.48%	+2.77%	$45M	1.6M	+467,868	+41.3%	$28.11	Q3 2022
9/30/2022	call		-0.64%	$0	0	-246,400	-100%	^*	Q3 2022
6/30/2022		7.8%	+2.61%	$30.5M	1.13M	+379,225	+50.4%	$26.96	Q2 2022
6/30/2022	call	0.63%	+0.63%	$2.48M	246K	+246,400	NEW	$10.05^*	Q2 2022
3/31/2022		8.32%	+5.81%	$25.6M	753K	+526,308	+232%	$34.06	Q1 2022
12/31/2021		4.68%		$8.76M	227K			$38.64	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.